Brad Thomas is a Global Medical Affairs Leader with a robust background in precision medicine and a commitment to improving patient health. They earned a PhD from the University of Calgary, focusing on bacteriophage as a chimeric vaccine scaffold and conducted postdoctoral research on hepatitis C at the University of Alberta. At AstraZeneca, they currently identify patients through testing pathways while previously achieving significant growth in territory as a Molecular Account Executive at Abbott. Brad's expertise spans various fields, including molecular biology, virology, and project management, complemented by a strong track record in consultative selling and building effective partnerships.
This person is not in the org chart
This person is not in any teams
This person is not in any offices